BT-001

Home/BT-001

BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment

AACR2020-BT-001 Jean-Baptiste Marchand et al. AACR 2020 Download the poster [...]

By |2020-06-22T18:32:23+02:00June 22nd, 2020|BT-001, BT-001, Invir.IO, Publication|Comments Off on BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment
Read More
Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166 67405 Illkirch Graffenstaden Cedex - France | Phone: + 33 (0) 3 88 27 91 00 - Fax: + 33 (0) 3 88 27 91 11
© 2018 Transgene - All rights reserved
Legal Notice - Credits
Go to Top